Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data
Abstract Background There is a need to better reflect the patient experience in multiple myeloma (MM), beyond just clinical progression, with the use of a novel endpoint that combines disease progression with patient-reported outcomes. Methods A systematic literature review (SLR) identified relevant...
Saved in:
| Main Authors: | Martin Kortüm, Sebastian Theurich, James Farrell, Graham Jackson, Gordon Cook, Joseph C. Cappelleri, Olivia Ashman, Shanti Neff-Baro, Aline Gauthier, Khalil Jewiti-Rigondza, Alaeddine Sidhom, Ashraf Chaudhary, Christof Scheid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14724-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selection of Endpoints for Clinical Studies of Ophthalmic Drugs
by: M. O. Komarova
Published: (2021-10-01) -
Rehabilitation of COVID-19 convalescents and its impact on cardiovascular endpoints: propensity score matching analysis
by: G. Kh. Lasynova, et al.
Published: (2023-12-01) -
Surrogate endpoints for neonatal outcome: A rapid review
by: Shiraz El Adam, et al.
Published: (2024-08-01) -
Surrogate endpoints in cost-effectiveness analysis for use in medical technology assessment
by: T. I. Busheva, et al.
Published: (2025-07-01) -
Surrogate endpoints in diabetic kidney disease: current perspectives and future directions
by: Can Cao, et al.
Published: (2025-05-01)